Great West Life Assurance CO Acadia Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 36,054 shares of ACAD stock, worth $672,767. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,054

Previous 39,766 9.33%

Holding current value

$672,767

Previous $647,000 14.06%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $56,199 - $71,047	-3,712 Reduced 9.33%	36,054 $556,000
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $60,802 - $92,959	2,926 Added 7.94%	39,766 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $66,146 - $106,233	3,174 Added 9.43%	36,840 $767,000
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $25,311 - $36,474	1,422 Added 4.41%	33,666 $812,000
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $13,545 - $17,363	-830 Reduced 2.51%	32,244 $608,000
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $188,221 - $246,940	13,255 Added 66.88%	33,074 $529,000
Q3 2022 Nov 01, 2022	BUY	$14.11 - $18.27 $279,646 - $362,093	19,819 New	19,819 $324,000
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $35,017 - $49,493	-1,805 Reduced 21.72%	6,505 $159,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $12,034 - $26,450	481 Added 6.14%	8,310 $213,000
Q3 2020 Nov 17, 2020	BUY	$36.42 - $57.0 $285,132 - $446,253	7,829 New	7,829 $0
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $285,132 - $446,253	-7,829 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $283,488 - $402,410	7,829 New	7,829 $0
Q3 2019 Oct 25, 2019	SELL	$22.22 - $44.01 $322,767 - $639,289	-14,526 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$23.32 - $28.12 $338,746 - $408,471	14,526 New	14,526 $0
Q1 2019 May 08, 2019	SELL	$16.17 - $27.38 $238,636 - $404,074	-14,758 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $42,516 - $68,049	2,969 Added 25.18%	14,758 $230,000
Q3 2017 Nov 09, 2017	BUY	$29.49 - $38.37 $347,657 - $452,343	11,789	11,789 $451,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.02B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Acadia Pharmaceuticals Inc Transaction History